Common Stock, Shares, Outstanding of aTYR PHARMA INC from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
aTYR PHARMA INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • aTYR PHARMA INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 98,031,104, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

aTYR PHARMA INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 98,031,104 +13,992,182 +17% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 97,986,634 +22,175,348 +29% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 92,871,182 +17,074,984 +23% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 89,002,825 +20,648,792 +30% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 84,038,922 +20,752,518 +33% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 75,811,286 +17,251,225 +29% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 75,796,198 +18,750,026 +33% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 68,354,033 +15,014,422 +28% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 63,286,404 +33,787,916 +115% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 58,560,061 +29,550,679 +102% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 57,046,172 +28,918,714 +103% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 53,339,611 +25,283,362 +90% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 29,498,488 +1,705,453 +6.1% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 29,009,382 +1,218,705 +4.4% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 28,127,458 +11,820,088 +72% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 28,056,249 +12,044,864 +75% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 27,793,035 +16,774,081 +152% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 27,790,677 +17,799,715 +178% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 16,307,370 +6,923,945 +74% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 16,011,385 +6,658,887 +71% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 11,018,954 +7,127,167 +183% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 9,990,962 +6,100,777 +157% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 9,383,425 +5,852,055 +166% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 9,352,498 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 3,891,787 +1,705,398 +78% 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 3,890,185 -25,975,324 -87% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 3,531,370 -26,325,591 -88% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 2,186,389 -27,602,773 -93% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 29,865,509 +149,711 +0.5% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 29,856,961 +6,019,757 +25% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 36,500,189 +12,719,213 +53% 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 29,789,162 +6,044,330 +25% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q3 2017 29,715,798 +5,997,269 +25% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 23,837,204 +119,521 +0.5% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 23,780,976 +103,673 +0.44% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 23,744,832 +74,753 +0.32% 31 Dec 2016 10-K 20 Mar 2018 2017 FY
Q3 2016 23,718,529 +79,249 +0.34% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 23,717,683 +78,403 +0.33% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 23,677,303 +22,647,572 +2199% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 23,670,079 +22,760,199 +2501% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 23,639,280 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 23,639,280 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 1,029,731 31 Mar 2015 10-Q 18 Jun 2015 2015 Q1
Q4 2014 909,880 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.